Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects

Abstract Background Metformin, the most widely administered diabetes drug, has been proposed as a candidate adjunctive host-directed therapy for tuberculosis, but little is known about its effects on human host responses to Mycobacterium tuberculosis. Methods We investigated in vitro and in vivo eff...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases Jg. 220; H. 1; S. 139 - 150
Hauptverfasser:	Lachmandas, Ekta, Eckold, Clare, Böhme, Julia, Koeken, Valerie A C M, Marzuki, Mardiana Binte, Blok, Bastiaan, Arts, Rob J W, Chen, Jinmiao, Teng, Karen W W, Ratter, Jacqueline, Smolders, Elise J, Van den Heuvel, Corina, Stienstra, Rinke, Dockrell, Hazel M, Newell, Evan, Netea, Mihai G, Singhal, Amit, Cliff, Jacqueline M, Van Crevel, Reinout
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	US Oxford University Press 05.06.2019
Schlagworte:	Cell Proliferation - drug effects Down-Regulation - drug effects Healthy Volunteers Host-Pathogen Interactions - drug effects Humans Hypoglycemic Agents - pharmacology Leukocytes, Mononuclear - drug effects Leukocytes, Mononuclear - microbiology Metformin - pharmacology Monocytes - drug effects Monocytes - metabolism Mycobacterium tuberculosis - pathogenicity Myeloid Cells - drug effects Myeloid Cells - metabolism Phagocytosis - drug effects Reactive Oxygen Species - metabolism Signal Transduction - drug effects Tuberculosis - metabolism Tuberculosis - microbiology Up-Regulation - drug effects gene transcription host-directed therapy Metformin antimycobacterial mechanisms tuberculosis
ISSN:	0022-1899, 1537-6613, 1537-6613
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!